Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1622229 · FYE Dec 31 · no price history on file
Mkt cap $6.5B
Price series unavailable — No prices available for COGT in [1900-01-01, 2026-07-30]. This symbol may require bring-your-own-key (BYOK) data.
| Short interest9.7% of sh out |
| Days to cover6.7d |
| 13F net flow (QoQ)+3.94% |
| Top-10 13F concentration48.3% |
| Next report (est.)2026-08-04 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$7.9M |
| Earnings (TTM)-$354.3M |
| ROE−73.7% |
| Debt / equity0.35× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
No return windows available for COGT.
No risk analytics available for COGT.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 23.1M | $890M | — | +0.2% |
| BlackRock, Inc. | 16.0M | $618M | — | +23.7% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 9.0M | $348M | — | +0.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.3M | $282M | — | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.9M | $265M | — | new |
| JANUS HENDERSON GROUP PLC | 6.0M | $230M | — | +31.5% |
| STATE STREET CORP | 5.7M | $218M | — | +14.6% |
| Fairmount Funds Management LLC | 5.5M | $212M | — | −38.9% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding suppressed: the summed institutional 13F holdings (186,329,564) exceed the cover-page shares-outstanding count for this quarter (162,308,820, as of 2026-02-13) by more than securities-lending double counting can explain (FINRA short interest 11,751,022 shares at 2026-04-30), so the share count is stale or wrong (common for annual 20-F foreign private issuers after a share issuance) and a percentage would be fabricated. Holder share counts are shown as filed.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | −$0.53 | — | — | — |
| 2025-09-30 | 2025-11-03 | −$0.50 | — | — | — |
| 2025-06-30 | 2025-08-05 | −$0.53 | — | — | — |
| 2025-03-31 | 2025-05-06 | −$0.52 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-04 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
